Literature DB >> 32506536

Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome.

Ting-Yu Yeh1,2,3, Gregory P Contreras1,2.   

Abstract

Entities:  

Keywords:  COVID-19; Epidemics; Infectious diseases; RNA virus infections; Respiratory tract infections; Virus diseases

Mesh:

Year:  2020        PMID: 32506536      PMCID: PMC7300921          DOI: 10.5694/mja2.50657

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   12.776


× No keyword cloud information.
to the editor: The coronavirus disease 2019 (COVID‐19) outbreak has become a public health emergency globally.1, 2 Until 26 May 2020, there were 7126 confirmed cases reported in Australia (https://coronavirus.jhu.edu/map.html). However, specimens of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) independently isolated in Australia (in Sydney, the Gold Coast and Melbourne)3 exhibited very unusual mutations, which have not been identified in other countries (Box, A). Panel A: Deletions and mutations in the primary, secondary and tertiary structures of the coronavirus disease 2019 (COVID‐19) s2m RNA genetic element based on the three‐dimensional crystal structure of the SARS virus. Conventional RNA helical base pairings are indicated in italics. Sequence complements are indicated using colour‐coded brackets. The G19 mutation (arrowhead) of the Australian SARS‐CoV‐2 is shown with purple colour. Asterisks label the RNA recombination breakpoints based on analysis of 1319 Australia SARS‐CoV‐2 sequences using Recco algorithm (https://recco.bioinf.mpi-inf.mpg.de/) (P < 0.002). Panel B: Schematic representation of the s2m RNA secondary structure of the SARS virus, with tertiary structural interactions indicated as long range contacts.4 Up to 29 April, 1319 sequences of the Australian SARS‐CoV‐2 isolates are available in the website of the Global Initiative on Sharing All Influenza Data (GISAID).3 Except for the NSW03 and NSW01 isolates, viral mutations are located at the stem‐loop II motif (s2m), an extremely conserved RNA element in the 3’ untranslated region (3’‐UTR) (Box, A). The NSW02 and VIC01 isolates have deletion of 41 and ten nucleotides respectively. All Queensland cases have single G‐to‐A substitution (nucleotides 29714/QLD01, 29736/QLD02, 29736/QLD04, and 29737/QLD03). Moreover, patients with NSW05, NSW06, NSW07, NSW15, NSW18, NSW19, NSW21, NSW24, NSW26, NSW28, or NSW31 (nucleotide 29696) have single G‐to‐U substitution at the same nucleotide. This substitution is only present in Australian patients and has not been found in SARS‐CoV‐2 isolates from other countries. Phylogenetic analysis showed that SARS and 30 other coronaviruses and astroviruses all possess the genetic element s2m, suggesting that this motif is conserved in both nucleotide sequence and secondary structure folding during evolution in an otherwise rapidly mutable RNA genome.3, 5 The three‐dimensional crystal structure of the s2m RNA element of the SARS virus shows that guanosine (19), which is mutated in Australian isolates, is critical for tertiary contacts to form an RNA base quartet involving two adjacent G–C pairs (G19, C20, G28, and C31)4 (Box, B). Because s2m plays an essential role for the viral RNA to substitute host protein synthesis, we hypothesise that the disruption of s2m could alter the viral viability or infectivity dramatically. The s2m sequence of coronaviruses is highly conserved, and spontaneous mutations in this motif were not expected to have occurred during the apparent short period when SARS‐CoV‐2 has been present; therefore, it is highly likely that the changes are due to recombination.5 Because a high frequency of recombination events in coronaviruses occurs, RNA recombination could either enhance the adaptation process to its new host like humans or cause unpredictable changes in virulence during infection.

Competing interests

No relevant disclosures.
  4 in total

1.  COVID-19, Australia: Epidemiology Report 13 (Reporting week to 23:59 AEST 26 April 2020).

Authors: 
Journal:  Commun Dis Intell (2018)       Date:  2020-05-01

2.  The structure of a rigorously conserved RNA element within the SARS virus genome.

Authors:  Michael P Robertson; Haller Igel; Robert Baertsch; David Haussler; Manuel Ares; William G Scott
Journal:  PLoS Biol       Date:  2004-12-28       Impact factor: 8.029

Review 3.  Distribution and Evolutionary History of the Mobile Genetic Element s2m in Coronaviruses.

Authors:  Torstein Tengs; Christine M Jonassen
Journal:  Diseases       Date:  2016-07-28

4.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

  4 in total
  6 in total

1.  Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome.

Authors:  Valeria Lulla; Michal P Wandel; Katarzyna J Bandyra; Rachel Ulferts; Mary Wu; Tom Dendooven; Xiaofei Yang; Nicole Doyle; Stephanie Oerum; Rupert Beale; Sara M O'Rourke; Felix Randow; Helena J Maier; William Scott; Yiliang Ding; Andrew E Firth; Kotryna Bloznelyte; Ben F Luisi
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

2.  Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France.

Authors:  Philippe Colson; Pierre-Edouard Fournier; Jeremy Delerce; Matthieu Million; Marielle Bedotto; Linda Houhamdi; Nouara Yahi; Jeremy Bayette; Anthony Levasseur; Jacques Fantini; Didier Raoult; Bernard La Scola
Journal:  J Med Virol       Date:  2022-05-06       Impact factor: 20.693

3.  Sequential Appearance and Isolation of a SARS-CoV-2 Recombinant between Two Major SARS-CoV-2 Variants in a Chronically Infected Immunocompromised Patient.

Authors:  Emilie Burel; Philippe Colson; Jean-Christophe Lagier; Anthony Levasseur; Marielle Bedotto; Philippe Lavrard-Meyer; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

4.  Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine.

Authors:  Ting-Yu Yeh; Gregory P Contreras
Journal:  Bull World Health Organ       Date:  2021-04-30       Impact factor: 9.408

Review 5.  Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development.

Authors:  Anais M Quemener; Maria Laura Centomo; Scott L Sax; Riccardo Panella
Journal:  Molecules       Date:  2022-01-15       Impact factor: 4.411

6.  Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.

Authors:  Siqi Wu; Chang Tian; Panpan Liu; Dongjie Guo; Wei Zheng; Xiaoqiang Huang; Yang Zhang; Lijun Liu
Journal:  J Med Virol       Date:  2020-11-01       Impact factor: 20.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.